Disc Medicine, Inc.
NASDAQ:IRONBiotechnology
-$0.02 today
- Market cap
- $2.99B
- Beta
- 2.10
- P/E (TTM)
- -11.2
- EPS (TTM)
- -$6.28
Volume 0.95M
Average 0.47M
IRON Short-term Debt
Borrowings and the current portion of long-term debt due within one year.
Disc Medicine, Inc.NASDAQ: IRON
Short-term Debt · Q3 FY2026 · quarter ended Sep 2026
Short-term debt remains negative
Q3 FY2026 short-term debt was $0, compared with $0 a year earlier.
Context
- Short-term debt amounted to 0.0% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Short-term debt increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 611K USD
- Year-over-year change
- —
- 4-year CAGR
- -40.9%
| Period | Period end | Short-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 611K | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 5M | — |
Short-term Debt vs competitors
How IRON compares with its peers on the latest reported figures
- IRON's Sep 2026 short-term debt of $0 is the 4th highest of the 6 companies compared; the peer median is $2.4M.
- Short-term debt amounts to 0.0% of total assets for IRON, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $20.4M | — | -4.1% | 3.8% | |
| Mar 2026 | $18.81M | — | — | 1.6% | |
| Jun 2026 | $2.4M | — | — | 0.3% | |
IRONDisc Medicine, Inc. | Sep 2026 | $0 | — | — | 0.0% |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $0 | — | — | 0.0% |
DMRADamora Therapeutics, Inc. | Mar 2026 | $0 | -100.0% | — | 0.0% |
| Peer median (excluding IRON) | $2.4M | -100.0% | -4.1% | 0.3% | |
Competitors are the stored peer set for IRON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 88.04M | 194.61M | 360.38M | 192.43M | 91.15M |
| Short-term Investments | 0 | 0 | 0 | 297.45M | 700.01M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (802K) | 0 | 0 | 3.73M | 12.75M |
| Total Current Assets | 90.48M | 198.49M | 365.66M | 493.62M | 803.9M |
| Property, Plant & Equipment (Net) | 1.75M | 1.6M | 2.1M | 2.32M | 2.26M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 180K | 116K | 234K | 838K | 726K |
| Total Non-current Assets | 1.93M | 1.71M | 2.33M | 3.16M | 2.98M |
| Total Assets | 92.41M | 200.21M | 368M | 496.77M | 806.88M |
| Account Payables | 2.56M | 16.16M | 12.63M | 7.95M | 9.02M |
| Short-term Debt | 5M | 0 | 0 | 0 | 611K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.45M | 3.62M | 5.79M | 7.21M | 27.01M |
| Total Current Liabilities | 13.42M | 22.58M | 21.44M | 23.32M | 36.64M |
| Long-term Debt | 404K | 0 | 0 | 28.32M | 1.25M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 141.45M | 0 | 0 | 0 | 29.16M |
| Total Non-current Liabilities | 143.19M | 1.03M | 1.44M | 29.87M | 30.41M |
| Total Liabilities | 156.61M | 23.61M | 22.88M | 53.19M | 67.05M |
| Common Stock | 0 | 2K | 2K | 3K | 4K |
| Retained Earnings | (65.39M) | (112.22M) | (188.65M) | (298M) | (510.19M) |
| Accumulated OCI | 0 | 0 | 0 | 289K | 965K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (64.2M) | 176.6M | 345.12M | 443.59M | 739.83M |
| Total Debt | 7.06M | 1.33M | 2.1M | 30M | 1.86M |
| Net Debt | (80.98M) | (193.28M) | (358.28M) | (162.43M) | (89.28M) |
Disc Medicine, Inc.
NASDAQ:IRON
Intrinsic Alpha fair value
Locked
Current Price
$77.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.